Abstract
1140P Cemiplimab versus historical systemic treatments for locally advanced (la) or metastatic (m) cutaneous squamous cell carcinomas (CSCC): Results from the French study TOSCA
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have